Latest Immunoglobulin E Stories
Researchers from Boston University School of Medicine (BUSM), in collaboration with researchers from the Inner City Asthma Consortium, have found that among inner-city children, the drug omalizumab improved asthma control, nearly eliminated seasonal exacerbations and reduced the need for controller medication.
A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial sponsored by the National Institutes of Health has found.
Cobalis Corp.'s PreHistin® Allergy Defense Formula, the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3.
IRVINE, Calif., March 10, 2011 /PRNewswire/ -- Cobalis Corp.'s (Pink Sheets: CLSC) http://www.prehistin.com/ [PreHistinÂ® Allergy Defense Formula], the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3.
A breakthrough by scientists at The University of Nottingham could provide hope for any allergy sufferers who have ever had to choose between their health and their household pet.
New research that reveals how maternal antibodies block an immune response to the measles virus is a first step toward improving current childhood vaccination practices, scientists say.
Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by UniversitÃ© de MontrÃ©al.
Leading Chain Pharmacy Order Signals Launch of National PreHistin Retail Marketing Program Irvine, CA (PRWEB) January 12, 2011 Cobalis Corp., (Pink Sheets: CLSC.PK) makers of PreHistin® Allergy Defense Formula, announced today that they have received a $415,000 opening purchase order via the Direct EDI ordering and invoicing system from one of the nationâ€™s two leading chain pharmacies, as well as opening orders from several other national and regional healthcare product...
For years, hospitals and researchers have been testing blood samples from the umbilical cords of newborn babies to assess the risk of allergy.
A new study estimates that 2.5 percent of the United States population, or about 7.6 million Americans, have food allergies.